A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This is a phase II study to investigate the safety, preliminary efficacy and pharmacokinetics of SC0062 capsule in patients with chronic kidney disease (diabetic kidney disease and IgA nephropathy)with albuminuria compared to matching placebo.
Epistemonikos ID: cd5d46c3c7d191789123c0501405b507cf1f19f3
First added on: Feb 19, 2024